Rowland & CO Investment Counsel Merck & Co., Inc. Transaction History

Rowland & CO Investment Counsel

$470 Million
Q1 2024

A detailed history of Rowland & CO Investment Counsel transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 45,413 shares of MRK stock, worth $5.71 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares

45,413

Previous 45,323 0.2%

Holding current value

$5.71 Million

Previous $4.94 Million 21.27%

% of portfolio

1.28%

Previous 1.14%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 08, 2024	BUY	$113.24 - $131.95 $10,191 - $11,875	90 Added 0.2%	45,413 $5.99 Million
Q4 2023 Jan 03, 2024	SELL	$100.18 - $109.02 $54,598 - $59,415	-545 Reduced 1.19%	45,323 $4.94 Million
Q3 2023 Oct 26, 2023	SELL	$102.95 - $114.33 $13,795 - $15,320	-134 Reduced 0.29%	45,868 $4.72 Million
Q2 2023 Aug 04, 2023	SELL	$108.61 - $118.38 $16,400 - $17,875	-151 Reduced 0.33%	46,002 $5.31 Million
Q1 2023 Apr 25, 2023	SELL	$102.94 - $114.86 $25,220 - $28,140	-245 Reduced 0.53%	46,153 $4.91 Million

Q3 2022 Oct 06, 2022	SELL	$84.53 - $94.96 $3,803 - $4,273	-45 Reduced 0.1%	46,398 $4 Million
Q1 2022 Apr 26, 2022	SELL	$73.51 - $82.4 $2,499 - $2,801	-34 Reduced 0.07%	46,443 $3.81 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $2,168 - $2,716	30 Added 0.06%	46,477 $3.56 Million
Q3 2021 Nov 08, 2021	SELL	$71.68 - $78.83 $48,025 - $52,816	-670 Reduced 1.42%	46,447 $3.49 Million
Q2 2021 Aug 09, 2021	BUY	$70.31 - $77.77 $3,867 - $4,277	55 Added 0.12%	47,117 $3.66 Million
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $69,410 - $81,758	1,008 Added 2.19%	47,062 $3.46 Million
Q4 2020 Feb 11, 2021	SELL	$71.77 - $79.65 $28,205 - $31,302	-393 Reduced 0.85%	46,054 $3.59 Million
Q1 2020 May 11, 2020	SELL	$63.36 - $87.82 $30,729 - $42,592	-485 Reduced 1.03%	46,447 $3.41 Million
Q4 2019 Jan 28, 2020	BUY	$77.58 - $87.54 $1,784 - $2,013	23 Added 0.05%	46,932 $4.07 Million
Q3 2019 Oct 02, 2019	SELL	$76.08 - $82.93 $23,052 - $25,127	-303 Reduced 0.64%	46,909 $3.77 Million
Q2 2019 Jul 09, 2019	SELL	$69.84 - $81.59 $35,548 - $41,529	-509 Reduced 1.07%	47,212 $0
Q1 2019 Apr 10, 2019	SELL	$69.58 - $79.36 $32,006 - $36,505	-460 Reduced 0.95%	47,721 $0
Q4 2018 Feb 12, 2019	SELL	$65.24 - $75.71 $3,522 - $4,088	-54 Reduced 0.11%	48,181 $3.51 Million
Q3 2018 Oct 22, 2018	SELL	$57.69 - $67.84 $5,769 - $6,784	-100 Reduced 0.21%	48,235 $0
Q2 2018 Jul 11, 2018	SELL	$50.83 - $59.72 $15,249 - $17,916	-300 Reduced 0.62%	48,335 $0
Q1 2018 Apr 17, 2018	BUY	$50.96 - $59.23 $142,178 - $165,251	2,790 Added 6.09%	48,635 $0
Q4 2017 Jan 11, 2018	SELL	$51.62 - $61.64 $104,530 - $124,821	-2,025 Reduced 4.23%	45,845 $0
Q3 2017 Oct 11, 2017	SELL	$58.67 - $63.13 $97,509 - $104,922	-1,662 Reduced 3.36%	47,870 $0
Q3 2017 Oct 11, 2017	BUY	$58.67 - $63.13 $2.91 Million - $3.13 Million	49,532	49,532 $0

Others Institutions Holding MRK

# of Institutions

3,770

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $319B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rowland & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Rowland & CO Investment Counsel with notifications on news.

Account

Rowland & CO Investment Counsel Merck & Co., Inc. Transaction History